HYDRAZINE PRODUCTION IN CHILDREN RECEIVING ISONIAZID FOR THE TREATMENT OF TUBERCULOUS MENINGITIS

被引:4
作者
DONALD, PR [1 ]
SEIFART, HI [1 ]
PARKIN, DP [1 ]
VANJAARSVELD, PP [1 ]
机构
[1] UNIV STELLENBOSCH,DEPT PHARMACOL,TYGERBERG 7505,SOUTH AFRICA
关键词
D O I
10.1177/106002809402801202
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: TO study the generation of the hepatotoxin hydrazine in 32 malnourished children receiving isoniazid for the treatment of tuberculous meningitis. DESIGN AND SETTING: This observational study was undertaken in the pediatric ward of a teaching hospital admitting children with advanced forms of tuberculous meningitis for treatment and management of complications. METHODS: Thirty-two children (mean age 2.28 years) receiving isoniazid 20 mg/kg/d were studied. Plasma isoniazid, acetyl isoniazid, and hydrazine concentrations were determined by an HPLC method. Fourteen children were studied at weekly intervals for the first month of treatment and again after six months of therapy; 18 additional children were studied on one or more occasions during the first month of treatment only. RESULTS: The area under the curve for hydrazine two to five hours after the isoniazid dose correlated with the isoniazid elimination rate and with acetylisoniazid generation. Hydrazine production increased significantly during the first month of treatment, but decreased to approximate initial values at six months. No correlation was found between any clinical or biochemical indicator of liver dysfunction and hydrazine production. CONCLUSIONS: Hydrazine is formed in significant concentrations during the metabolism of isoniazid in young children. However, additional factors such as preexisting liver damage (e.g., from viral hepatitis) may be necessary for it to reach its toxic potential.
引用
收藏
页码:1340 / 1343
页数:4
相关论文
共 20 条
[1]   KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].
ACOCELLA, G ;
BONOLLO, L ;
TENCONI, LT ;
GARIMOLDI, M ;
MAINARDI, M ;
NICOLIS, FB .
GUT, 1972, 13 (01) :47-+
[2]  
Balo J, 1979, Adv Cancer Res, V30, P151, DOI 10.1016/S0065-230X(08)60896-9
[3]   PLASMA HYDRAZINE CONCENTRATIONS IN MAN AFTER ISONIAZID AND HYDRALAZINE ADMINISTRATION [J].
BLAIR, IA ;
TINOCO, RM ;
BRODIE, MJ ;
CLARE, RA ;
DOLLERY, CT ;
TIMBRELL, JA ;
BEEVER, IA .
HUMAN TOXICOLOGY, 1985, 4 (02) :195-202
[4]   HEPATIC TOXICITY DURING CHEMOTHERAPY FOR SEVERE TUBERCULOUS MENINGITIS [J].
DONALD, PR ;
SCHOEMAN, JF ;
OKENNEDY, A .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (07) :741-743
[5]   PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN [J].
ELLARD, GA ;
GAMMON, PT .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02) :83-113
[6]   INH AND STREPTOMYCIN IN ETHIOPIAN CHILDREN WITH TUBERCULOSIS AND DIFFERENT NUTRITIONAL-STATUS [J].
ERIKSSON, M ;
BOLME, P ;
HABTE, D ;
PAALZOW, L .
ACTA PAEDIATRICA SCANDINAVICA, 1988, 77 (06) :890-894
[7]   FACTORS IN HYDRAZINE FORMATION FROM ISONIAZID BY PEDIATRIC AND ADULT TUBERCULOSIS PATIENTS [J].
GENT, WL ;
SEIFART, HI ;
PARKIN, DP ;
DONALD, PR ;
LAMPRECHT, JH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) :131-136
[8]  
Gibaldi M., 1982, PHARMACOKINETICS DRU, P15
[9]  
GIRLING DJ, 1978, TUBERCLE, V59, P13
[10]   PHYSICAL GROWTH - NATIONAL-CENTER-FOR-HEALTH-STATISTICS PERCENTILES [J].
HAMILL, PVV ;
DRIZD, TA ;
JOHNSON, CL ;
REED, RB ;
ROCHE, AF ;
MOORE, WM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (03) :607-629